Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, B-Cell, Marginal Zone × veliparib × 30 days × Clear all

Sponsor

Conditions

Breast Neoplasms 3 Glioblastoma 2 Triple Negative Breast Neoplasms 1 Thrombocythemia, Essential 1 Testicular Neoplasms 1 Renal Insufficiency 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Ovarian Neoplasms 1 Neoplasms, Unknown Primary 1 Neoplasm Metastasis 1 Myelodysplastic-Myeloproliferative Diseases 1 Melanoma 1 Lung Neoplasms 1 Liver Failure 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1 Head and Neck Neoplasms 1 Gliosarcoma 1 Glioma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Carcinoma, Transitional Cell 1 Brain Neoplasms 1 Astrocytoma 1 Ann Arbor Stage III Non-Hodgkin Lymphoma 1 Advanced Malignant Solid Neoplasm 1 Adenocarcinoma, Bronchiolo-Alveolar 1 Adenocarcinoma of Lung 1

Interventions

Rituximab 8 Lenalidomide 5 Cyclophosphamide 5 ibrutinib 3 Vincristine 3 Prednisone 3 CT-P10 3 venetoclax 2 orelabrutinib 2 Specimen Handling 2 Magnetic Resonance Spectroscopy 2 Doxorubicin 2 zanubrutinib 1 tafasitamab 1 prednylidene 1 polatuzumab vedotin 1 obinutuzumab 1 ianalumab 1 fludarabine phosphate 1 fludarabine 1 deltacortene 1 cc-486 1 acalabrutinib 1 Whole-Body Irradiation 1 Transplantation 1 Tacrolimus 1 Radiotherapy 1 R-CHOP protocol 1 Pharmacogenomic Testing 1 Peripheral Blood Stem Cell Transplantation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡